Carmichael Hill & Associates, Inc. Merck & Co., Inc. Transaction History

Carmichael Hill & Associates, Inc.

$279 Million
Q3 2024

A detailed history of Carmichael Hill & Associates, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 6,280 shares of MRK stock, worth $622,850. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,280

Previous 6,234 0.74%

Holding current value

$622,850

Previous $771,000 7.52%

% of portfolio

0.26%

Previous 0.31%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$111.15 - $128.97 $5,112 - $5,932	46 Added 0.74%	6,280 $713,000
Q2 2024 Aug 02, 2024	BUY	$123.8 - $132.96 $22,903 - $24,597	185 Added 3.06%	6,234 $771,000
Q1 2024 Apr 24, 2024	SELL	$113.24 - $131.95 $5,209 - $6,069	-46 Reduced 0.75%	6,049 $798,000
Q4 2023 Jan 23, 2024	SELL	$100.18 - $109.02 $20,036 - $21,804	-200 Reduced 3.18%	6,095 $664,000
Q2 2023 Aug 04, 2023	SELL	$108.61 - $118.38 $104,917 - $114,355	-966 Reduced 13.3%	6,295 $726,000
Q1 2023 Apr 05, 2023	SELL	$102.94 - $114.86 $26,867 - $29,978	-261 Reduced 3.47%	7,261 $772,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $25,095 - $32,175	-287 Reduced 3.68%	7,522 $834,000
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $26,457 - $29,722	313 Added 4.18%	7,809 $673,000
Q2 2022 Aug 05, 2022	BUY	$83.49 - $94.64 $37,737 - $42,777	452 Added 6.42%	7,496 $683,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $52,265 - $58,586	-711 Reduced 9.17%	7,044 $578,000
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $1,084 - $1,358	15 Added 0.19%	7,755 $594,000
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $4,372 - $4,808	61 Added 0.79%	7,740 $581,000
Q1 2021 Apr 28, 2021	SELL	$68.86 - $81.11 $10,329 - $12,166	-150 Reduced 1.92%	7,679 $592,000
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $3,168 - $4,391	-50 Reduced 0.63%	7,829 $602,000
Q4 2019 Jan 30, 2020	BUY	$77.58 - $87.54 $8,688 - $9,804	112 Added 1.44%	7,879 $717,000
Q3 2019 Nov 06, 2019	BUY	$76.08 - $82.93 $7,684 - $8,375	101 Added 1.32%	7,767 $654,000
Q2 2019 Jul 30, 2019	SELL	$69.84 - $81.59 $13,898 - $16,236	-199 Reduced 2.53%	7,666 $643,000
Q4 2018 Jan 16, 2019	SELL	$65.24 - $75.71 $3,914 - $4,542	-60 Reduced 0.76%	7,865 $601,000
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $12,634 - $14,856	-219 Reduced 2.69%	7,925 $562,000
Q1 2018 Apr 27, 2018	BUY	$50.96 - $59.23 $12,790 - $14,866	251 Added 3.18%	8,144 $444,000
Q4 2017 Feb 07, 2018	BUY	$51.62 - $61.64 $407,436 - $486,524	7,893	7,893 $444,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.

Account

Carmichael Hill & Associates, Inc. Merck & Co., Inc. Transaction History